Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Tables)

v3.20.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Schedule of segment reporting information
    Three Months Ended
March 31,
 
    2020     2019  
Revenues            
Real property operations   $ 296,956     $ 266,626  
Medical related consulting services - related party     -       14,260  
Development services and sales of developed products     -       3,278  
Total     296,956       284,164  
Costs and expenses                
Real property operations     254,501       230,759  
Medical related consulting services - related party     -       13,091  
Development services and sales of developed products     -       30,307  
Total     254,501       274,157  
Gross profit (loss)                
Real property operations     42,455       35,867  
Medical related consulting services - related party     -       1,169  
Development services and sales of developed products     -       (27,029 )
Total     42,455       10,007  
Other operating expenses                
Real property operations     110,816       109,906  
Medical related consulting services - related party     155,235       179,128  
Development services and sales of developed products     35,999       220,881  
Corporate/Other     2,962,597       3,965,405  
Total     3,264,647       4,475,320  
Other income (expense)                
Interest expense                
Real property operations     -       24,658  
Corporate/Other     42,169       2,983  
Total     42,169       27,641  
Other income (expense)                
Real property operations     (935 )     8  
Medical related consulting services - related party     (5,487 )     (12,111 )
Development services and sales of developed products     2       128  
Total     (6,420 )     (11,975 )
Total other income (expense)     (48,589 )     (39,616 )
Net loss                
Real property operations     69,296       98,689  
Medical related consulting services - related party     160,722       190,070  
Development services and sales of developed products     35,997       247,782  
Corporate/Other     3,004,766       3,968,388  
Total   $ 3,270,781     $ 4,504,929  

 

Identifiable long-lived tangible assets at March 31, 2020 and December 31, 2019   March 31,
2020
    December 31,
2019
 
Real property operating   $ 7,709,622     $ 7,750,743  
Medical related consulting services     245,763       263,621  
Development services and sales of developed products     294,620       322,741  
Total   $ 8,250,005     $ 8,337,105  

 

Identifiable long-lived tangible assets at March 31, 2020 and December 31, 2019   March 31,
2020
    December 31,
2019
 
United States   $ 7,792,753     $ 7,839,093  
China     457,252       498,012  
Total   $ 8,250,005     $ 8,337,105